Valuation: Roopa Industries Limited

Market Cap 341M 3.6M 3.21M 2.97M 2.7M 5.07M 5.15M 35.64M 14M 178M 13.49M 13.21M 570M P/E 2025
19.8x
P/E 2026 371x
Enterprise Value 651M 6.86M 6.11M 5.67M 5.15M 9.68M 9.82M 67.96M 26.69M 340M 25.73M 25.18M 1.09B EV / Sales 2025
0.58x
EV / Sales 2026 0.48x
Free-Float
36.13%
Yield 2025 *
-
Yield 2026 -
1 day-2.30%
1 week-11.59%
Current month-5.47%
1 month-1.63%
3 months-11.39%
6 months-19.65%
Current year-1.48%
1 week 41.8
Extreme 41.8
48.45
1 month 40.71
Extreme 40.71
55
Current year 38.1
Extreme 38.1
63.4
1 year 38.1
Extreme 38.1
63.4
3 years 38.1
Extreme 38.1
114.9
5 years 15.4
Extreme 15.4
114.9
10 years 6.82
Extreme 6.82
114.9
Manager TitleAgeSince
Chief Executive Officer 72 1997-12-31
Director of Finance/CFO - 2020-06-30
Compliance Officer - 2022-05-31
Director TitleAgeSince
Chairman 72 1997-12-31
Director/Board Member 70 1997-03-16
Director/Board Member 54 2017-08-25
Change 5-day change 1-year change 3-year change Capi.($)
-2.30%-11.59%-18.81%-15.67% 3.68M
-1.33%+5.18%+54.50%+104.26% 1,120B
-0.69%-2.93%+31.35%+66.17% 616B
-0.96%+2.25%+23.13%+89.36% 504B
+0.24%+6.23%+33.98%+52.38% 367B
-1.59%-1.35%+69.39%+40.83% 360B
-0.40%+4.28%+19.17%+42.51% 288B
-0.37%+3.35%-1.26%+16.85% 258B
-1.75%+2.43%+42.21%+49.85% 234B
-2.00%+1.26%+24.64%+92.13% 194B
Average -1.04%+2.03%+27.83%+53.87% 394.09B
Weighted average by Cap. -0.87%+3.52%+37.90%+71.72%

Financials

2025 2026
Net sales 1.21B 12.77M 11.38M 10.55M 9.6M 18.02M 18.29M 127M 49.69M 633M 47.9M 46.88M 2.02B 1.28B 13.44M 11.99M 11.11M 10.1M 18.97M 19.26M 133M 52.33M 666M 50.44M 49.37M 2.13B
Net income 20.35M 214K 191K 177K 161K 303K 307K 2.12M 835K 10.63M 804K 787K 33.99M 831K 8.76K 7.81K 7.24K 6.58K 12.36K 12.54K 86.77K 34.08K 434K 32.85K 32.15K 1.39M
Net Debt 299M 3.15M 2.81M 2.6M 2.37M 4.44M 4.51M 31.21M 12.26M 156M 11.81M 11.56M 499M 310M 3.26M 2.91M 2.7M 2.45M 4.6M 4.67M 32.33M 12.7M 162M 12.24M 11.98M 517M
Projected Income Statement - Annual - Roopa Industries Limited
Logo Roopa Industries Limited
Roopa Industries Limited is an India-based active pharma ingredient (API) and pharmaceutical intermediates manufacturing company. The Company is focused on its core business Triphenyl Phosphine (TPP) and its allied products. Its products include N,N- Dicyclohexylcarbodiimide (DCC); TPP; 5-Cyano Phthalide, and bromine and its derivatives. TPP is a product used by the manufacturers of Cephalosporin group of Antibiotics, Statins and others. TTP are more used in areas like specialty resins/paints, fire retardants, Phosphonium salts, phase transfer catalysts, products relating to agriculture and others. Glucosamine is a sheet anchor product of the Company, which is a nutraceutical/nutritional supplement. It has capabilities to deliver bromine and bromine compounds of any quantity and specifications, such as Meta Bromo Anisole, Tetra Butyl Ammonium Bromide, 1-Bromo-3-Chloropropane, 1-Acetoxy Ethyl Bromide and others, which are used in chemical and pharmaceutical industry.
Employees
56
Date Price Change Volume
26-10-19 ₹43.39 -2.30% 1,433
26-10-16 ₹44.41 -5.43% 365
26-10-15 ₹46.96 +2.76% 1,598
26-10-14 ₹45.70 +0.77% 63
26-10-13 ₹45.35 -8.38% 362
  1. Stock Market
  2. Stocks
  3. ROOPAIND6 Stock